Immunotherapy
Finding ways to stimulate the body's immune system to help attack cancer cells is a growing area of research at The Institute of Cancer Research.
Clinical trials led by the ICR and our hospital partner The Royal Marsden have shown that the immunotherapy drug pembrolizumab can help extend the lives of some patients with advanced head and neck cancer, and prostate cancer.
The use of 'oncolytic' viruses, which can kill cancer cells both directly and by directing the immune system against them, is also an exciting area of research being explored by ICR researchers.
This page highlights recent news stories, blog posts and videos that concern immunotherapy research at the ICR.
Related pages
Latest ICR News
Neoadjuvant radiotherapy may hamper immunotherapy, new breast cancer research finds
A new study has provided novel insights into the effects of radiation on the immune cells surrounding breast cancer tumours.
Scientists create new way to predict bowel cancer risk in people with inflammatory bowel disease
Scientists at The Institute of Cancer Research, London have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer.